Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

I C U Medical Inc (ICUI)

I C U Medical Inc (ICUI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

I C U Medical Inc 951 CALLE AMANECER SAN CLEMENTE CA 92763 USA

www.icumed.com Employees: 15,000 P: 949-366-2183 F: 949-366-8368

Sector:

Medical

Description:

ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels.

Key Statistics

Overview:

Market Capitalization, $K 3,419,890
Enterprise Value, $K 4,694,180
Shares Outstanding, K 24,687
Annual Sales, $ 2,382 M
Annual Net Income, $ -117,690 K
Last Quarter Sales, $ 536,990 K
Last Quarter Net Income, $ -3,400 K
EBIT, $ 74,890 K
EBITDA, $ 301,210 K
60-Month Beta 0.80
% of Insider Shareholders 1.50%
% of Institutional Shareholders 96.10%
Float, K 24,317
% Float 98.50%
Short Interest 1,316
Short Float 5.33%
Short Volume Ratio 0.47

Growth:

1-Year Return -9.12%
3-Year Return -18.64%
5-Year Return -33.11%
5-Year Revenue Growth 88.12%
5-Year Earnings Growth -34.92%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 2.03 on 11/06/25
Next Earnings Date 02/26/26
Earnings Per Share ttm 6.38
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 34.96%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Most Recent Dividend 1.500 on 03/18/02
Dividend Payout Ratio 0.00%
Most Recent Split 3-2 on 03/18/02

ICUI Ratios

Ratio
Price/Earnings ttm 22.36
Price/Earnings forward 22.15
Price/Earnings to Growth N/A
Return-on-Equity % 7.71%
Return-on-Assets % 3.81%
Profit Margin % -4.94%
Debt/Equity 0.62
Price/Sales 1.54
Price/Cash Flow 10.18
Price/Book 1.66
Book Value/Share 86.16
Interest Coverage -0.31
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar